Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-02-14-Speech-2-220-875"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20120214.15.2-220-875"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"−
This text is a recommendation for second reading on the Council position at first reading with a view to the adoption of a directive of the European Parliament and of the Council amending Directive 2000/75/EC as regards vaccination against bluetongue. Bluetongue is a disease that mainly affects ruminant animals such as sheep, goats and cows, and may take on epidemic proportions under the right environmental and climatic conditions, particularly in late summer and early autumn. Although there is no record of human infection, it is vital to implement measures leading to its eradication. In November 2010, the European Union adopted a series of measures to eradicate it: specifically, a vaccination plan using what is known as ‘active immunisation’. However, what is known as ‘passive immunisation’ has been developed in recent years; in contrast to the older type, this can be used outside areas subject to restrictions. In view of the technological and scientific innovation in veterinary terms, I voted for this recommendation because it will make the vaccination programme against bluetongue more efficient, so reducing the costs to the farming sector of this disease."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples